First European psychedelic drug trial clinic opens in the U.K.
Clerkenwell Health will begin trials in its London in August, initially focusing on psilocybin treatments and poised to make the U.K. a leader psychedelic research.
Public health & disease
Levi Strauss & Co. to reimburse abortion travel for employees
The apparel company best known for its jeans is the latest U.S. company to offer the benefit as various states clamp down on access to abortions.
Landmark study finds first biomarker to detect babies at risk of SIDS
A team of researchers in Australia have now identified a blood biomarker linked to brain arousal that could potentially be used to identify infants most at risk of SIDS.
Canada removes ban on blood donations from gay men
Prospective donors will not be asked about their sexual orientation during the screening process but instead about whether they engage in any higher-risk sexual behavior.
Connecticut expands abortion rights to balance new wave of restrictions
Advanced practice registered nurses, nurse-midwives, and physician assistants will now be permitted to conduct medication and aspiration abortions in Connecticut.
Landmark DNA study finds 58 new mutations that cause cancer
The landmark findings from a massive study of more than 12,000 cancer patients offer researchers a trove of new resources to guide future studies on tailored cancer treatments.
First COVID-19 breath test authorized for use in U.S.
The device takes three minutes to return results and has been found to be over 90 percent accurate in detecting positive COVID-19 cases.
New treatment helps alopecia patients regrow their hair
A new Yale study shows that one in three patients with a severe skin disease were able to regrow hair after being treated with a common arthritis drug.
Psilocybin therapy changes brain wiring in depressed people, new study finds
The new study led by researchers from Imperial College London found that people also reported a reduction in their depression symptoms alongside these brain changes.
New blood test predicts risk of heart attack and stroke with twice previous accuracy
Scientists from SomaLogic in Boulder, CO have developed a blood test that can predict whether someone is at high risk of a heart attack, stroke, heart failure within the next four years.